tiprankstipranks
Trending News
More News >
ACADIA Pharmaceuticals (ACAD)
NASDAQ:ACAD

ACADIA Pharmaceuticals (ACAD) Revenue

Compare
2,418 Followers

ACADIA Pharmaceuticals Revenue

ACADIA Pharmaceuticals had a revenue of 278.63M in the quarter ending Sep 30, 2025, with 5.32%. This bring the company's revenue in the last twelve months to 1.05B, Decreased 2.77%. In the fiscal year ending Dec 31, 2024, ACADIA Pharmaceuticals had annual revenue of 957.80M with 31.85% growth.
Revenue (ttm)
1.05B
Revenue Growth
12.69%
P/S Ratio
4.80
Revenue/Employee
$1,466,764
Employees
653
Market Cap
$4.59B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
957.80M231.36M+131.85%
Dec 31, 2023
726.44M209.20M+140.45%
Dec 31, 2022
517.24M33.09M+106.83%
Dec 31, 2021
484.14M42.39M+109.60%
Dec 31, 2020
441.75M102.68M+130.28%
Dec 31, 2019
339.08M115.27M+151.50%
Dec 31, 2018
223.81M98.91M+179.19%
Dec 31, 2017
124.90M107.57M+720.68%
Dec 31, 2016
17.33M